Therefore, by overexpressing DHRS3 in cells with hypo-phosphorylated RARαS77 (Fig. 7g), we sought to investigate whether DHRS3 might offset the anti-tumor action of RARαS77A. Here, DHRS3 is linked to neoplasm.